|

Omeprazole Clinical Trials

4 actively recruiting trials across 3 locations

No change since May 2026

Also known as: Prilosec

Pipeline

Early 1: 1Phase 1: 3

Top Sponsors

  • University of Oklahoma1
  • Murdoch Childrens Research Institute1
  • Gilead Sciences1
  • Genentech, Inc.1

Indications

  • Cancer3
  • Weight Management1
  • Exocrine Pancreatic Cancer1
  • Diabetes1
  • Hodgkin Lymphoma1

Other1 trial

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Phase 1

Miami, Florida1 trial

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Qps-Mra, Llc.

Phase 1

Grand Rapids, Michigan1 trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

START - Midwest - EDOS

Phase 1

Oklahoma City, Oklahoma1 trial

High Dose Omeprazole in Patients With Pancreatic Cancer

Stephenson Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.